Skidmore College
Saratoga Springs, New York, 12866, United States
Location status: Recruiting
NCT Number: NCT06363305
The investigators long-term goal is to better understand novel interventions to promote cardiovascular health in humans. The goal of the proposed research is to investigate whether there is sex-specificity in the effects of dietary capsaicin on mechanisms regulating nitric oxide (NO) bioavailability, its effect on key markers of cardiovascular (CV) health, including BP, macro- and microvascular function, and arterial stiffness. This knowledge will provide critical insight into the effects of dietary capsaicin on CV health and will guide future trials.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Saratoga Springs, New York, 12866, United States
Location status: Recruiting
Specific Aim 1: Determine the sex-specific effects of dietary capsaicin on central and peripheral blood pressure and arterial stiffness. The investigators hypothesize that dietary capsaicin intervention (6 week) will improve BP and arterial stiffness, likely in a sex-dependent manner. The investigators will measure heart rate variability and excretion of capsaicin and metabolites to ascertain bioavailability, and understand the mechanistic role of the autonomic nervous system, in capsaicin's effect on BP.
Specific Aim 2: Assess whether dietary capsaicin effects on vascular function is sex-specific. The investigators hypothesize that dietary capsaicin intervention (6 week) will improve NO bioavailability, through improved redox balance and lowered asymmetric dimethylarginine, thereby improving peripheral vascular function, likely in a sex-dependent manner.
Utilizing a double-blind, randomized, placebo-controlled, design the investigators will investigate whether there is sex-specificity in the effects of a 6-week dietary capsaicin intervention on nitric oxide (NO) bioavailability, BP, vascular function, and arterial stiffness.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Daily doses of dietary capsaicin or placebo in capsule form
Time frame: Baseline, 24 hours, and 6-weeks
The investigators will assess peripheral and estimated central blood pressures and vascular stiffness using pulse wave analysis.
Time frame: Baseline, 24 hours, and 6-weeks
The investigators will assess HR and HRV using electrocardiogram and standard techniques to determine time and frequency domain estimates of HRV.
Time frame: Baseline, 24 hours, and 6-weeks
The investigators will assess brachial artery flow-mediated dilation using ischemia-reperfusion and ultrasound doppler to assess the dilatory capacity and reactive hyperemia.
Time frame: Baseline, 24 hours, and 6-weeks
The investigators will assess the hyperemic response to passive leg movement using ultrasound doppler.
Time frame: Baseline, 24 hours, and 6-weeks
The investigators will assess the metabolic capacity and vascular reactivity using ischemia-reperfusion and NIRS
Time frame: Baseline, 24 hours, and 6-weeks
The investigators will collect urine to determine urinary capsaicin and associated metabolites to understand bioavailability and potential relation to function.
Time frame: Baseline and 6-weeks
The investigators will collect blood to determine blood lipids (cholesterol) and glucose.
Contact information is provided by the study sponsor or research team.
Skidmore College
Other
Impact of Sex in the Effect of Dietary Capsaicin on Cardiovascular Health: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06917729
Cardiovascular Diseases, Hypertension
Porto Alegre, Rio Grande do Sul, Brazil
View Trial DetailsNCT01760239
Body Weight, Cardiovascular Diseases
Minneapolis, Minnesota, United States
View Trial DetailsNCT07453550
Cardiovascular Diseases, Hypertension
West Hartford, Connecticut, United States
View Trial DetailsNCT04692467
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Port-au-Prince, Haiti
View Trial Details